Explore UAB

Division of Pulmonary, Allergy and Critical Care Medicine

The UAB Lung Biology Program prioritizes mentoring junior investigators with hands-on training tailored to individual needs, involving trainees in all research stages from basic lab experiments and animal modeling to clinical visits and data analysis.

Training Lung Biology Program header image adobe stock # 633523073

Trainees expand their knowledge through our scientific expertise and the monthly PRESS lectures within the UAB T32 grant, focusing on research methodologies. Additionally, they are encouraged to participate in career development workshops by the UAB Center for Clinical and Translational Science (CCTS), fostering professional growth. This comprehensive training not only equips our junior investigators with essential skills and knowledge for their research endeavors, but also fosters a supportive environment for their professional growth.

Supported by an NIH T32 grant led by Dr. Gaggar, our program offers up to two annual pilot awards to nurture future scientists. It plays a crucial role in helping trainees secure NIH K-series awards and other career development grants.

 

T32 Postdoctoral Training Program

Applications are due at the end of April by 5:00 p.m.

The NIH-funded Postdoctoral Training Program in Lung Biology and Translational Medicine offers extensive research opportunities, intensive education, career development, and mentorship from top Pulmonary Medicine experts, with a strong track record of developing postdoctoral trainees into independent investigators. This program has two positions available starting July 1, 2024. Applicants should plan a career in clinical, translational, and basic science research related to the National Heart, Lung, and Blood Institute's mission.

Apply Here

 


 

The Lung Biology Program (LBP) Pilot Award

Proposals are due November 1.

The Lung Biology Program at the Lung Health Center is offering up to two pilot grants of $20,000 max each. Preference is given to proposals on pulmonary illnesses such as cystic fibrosis, COVID-19, asthma, COPD, interstitial lung disease, and critical care medicine, aiming to secure future extramural funding from the NIH or other external funding agencies.

Apply Here